Patient Pathfinder: Clinical Trials
Clinical Trials for Ovarian Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 444 active Ovarian Cancer trials
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Study Type: Interventional Phase 3
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Study Type: Interventional Phase 1
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Study Type: Interventional Phase 1
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
Study Type: Interventional Phase 2
Combination Therapy for Recurrent Ovarian Cancer
Study Type: Interventional Phase 1
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Study Type: Interventional Phase 1
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
Study Type: Interventional
A Study of Sovilnesib in Subjects With Ovarian Cancer
Study Type: Interventional Phase 1
There are 444 active Ovarian Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now